WallStreetZenWallStreetZen

NASDAQ: COEP
Coeptis Therapeutics Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their COEP stock forecasts and price targets.

Forecast return on equity

Is COEP forecast to generate an efficient return?

Company
-184.41%
Industry
109.86%
Market
50.2%
COEP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is COEP forecast to generate an efficient return on assets?

Company
-88.81%
Industry
90.31%
COEP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

COEP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
COEP$9.59N/AN/A
ESLA$0.94$16.00+1,602.13%Strong Buy
LVTX$1.26$3.17+151.35%Hold
ANVS$1.69$17.00+905.92%Strong Buy
ACRV$1.10$15.00+1,263.64%Buy
View Top Biotech Stocks

Coeptis Therapeutics Holdings Stock Forecast FAQ

What is COEP's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: COEP) forecast ROE is -184.41%, which is considered weak.

If you're new to stock investing, here's how to buy Coeptis Therapeutics Holdings stock.

What is COEP's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: COEP) forecast ROA is -88.81%, which is lower than the forecast US Biotechnology industry average of 90.31%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.